Indazole derivatives as jnk inhibitors

Details for Australian Patent Application No. 2001279089 (hide)

Owner Signal Pharmaceuticals, Inc.

Inventors Satoh, Yoshitaka; Bhagwat, Shripad S.; Sakata, Steven T.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001279089

PCT Pub. Number WO02/10137

Priority 60/221,799 31.07.00 US

Filing date 30 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 2 February 2006

International Classifications

C07D 231/00 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

2 February 2006 Application Accepted

  Published as AU-B-2001279089

1 June 2006 Standard Patent Sealed

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001279090

2001279088